Ennov, a France-based global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, has received a strategic growth investment in support of its continued expansion, with a focus on AI innovation, global commercial acceleration, and scaling of its product offering.
The financing was led...
Adragos Pharma, a Germany-based global CDMO, has appointed Konstantinos (Kostas) Rengis as its new CEO, succeeding company founder and CEO for the last six years, Dr Andreas Raabe. Raabe will remain a shareholder of Adragos and continue to support the company while shifting his focus from daily operations toward investment activities and advisory support.
Rengis brings extensive international leadership experience across pharmaceutical manufacturing, R&D and CDMO operations, leading organisations across Europe, North America, Latin America and Asia. Most recently, he served as Group CEO of FAMAR.
Since its founding, Adragos has...